PPARG and metabolic dysfunction-associated steatotic liver disease: In addition, excessive ROS activates hepatic C/EBPα and PPARγ, key transcription factors that control many lipogenic genes, such as FASN, FABP4, and SCD, to promote NAFLD progression [65,66].